Bevacizumab and ICIs + hSRT in Symptomatic Melanoma Brain Metastases

Conditions: Melanoma Brain Metastases Interventions: Drug: Bevacizumab; Drug: Ipilimumab; Drug: Nivolumab; Radiation: Hypofractionated stereotactic radiotherapy Sponsors: Melanoma and Skin Cancer Trials Limited Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials